Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients.
about
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus.The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study.Effects of Duodenal-Jejunal Bypass Liner (EndoBarrier®) on Gastric Emptying in Obese and Type 2 Diabetic Patients.
P2860
Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Duodenal-jejunal bypass liner ...... us in morbidly obese patients.
@en
type
label
Duodenal-jejunal bypass liner ...... us in morbidly obese patients.
@en
prefLabel
Duodenal-jejunal bypass liner ...... us in morbidly obese patients.
@en
P2860
P1476
Duodenal-jejunal bypass liner ...... us in morbidly obese patients.
@en
P2093
Alex Escalona
Rodrigo Muñoz
P2860
P2888
P356
10.1007/S11886-013-0454-3
P577
2014-03-01T00:00:00Z
P5875
P6179
1001132091